Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Clinical trial NCT04991103 · RECRUITING
Trial details
- NCT number
- NCT04991103
- Sponsor
- University of Alabama at Birmingham
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2027-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.